News

Dominic Brisby, Chief Executive Officer and Director of Nomad Foods Ltd, filed a Form 4 on November 4, 2026, disclosing a disposition of 70,500 ordinary shares on November 3, 2026, as well as reporting existing derivative security holdings.

Joseph Duxbury, Chief Accounting Officer of Vireo Growth Inc., filed a Form 4 on November 4, 2026, disclosing the acquisition of 63,000 stock options with an exercise price of $7.35 per share, granted on November 3, 2026.

Michael Marinaro, President of Medtronic plc, filed a Form 4 on November 4, 2026, disclosing equity awards granted on November 2, 2026, including restricted stock units, performance share units, and stock options.

Director Michael L. Steiner of Vireo Growth Inc. filed a Form 4 on November 4, 2026, disclosing the acquisition of stock options and restricted stock units on November 3, 2026.

Director Linda T. Hollembaek filed a Form 4 with the SEC on November 4, 2026, reporting the sale of 1,315 shares of Manhattan Associates Inc common stock on November 3, 2026.

Director Rainer Gawlick filed a Form 4 with the SEC on November 4, 2026, disclosing a purchase of Proto Labs Inc common stock on November 3, 2026.

Proto Labs Inc President and CEO Suresh Krishna filed a Form 4 on November 4, 2026, disclosing an open-market purchase of 750 shares of Proto Labs common stock on November 2, 2026.